CareDx Inc
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution … Read more
Market Cap & Net Worth: CareDx Inc (CDNA)
CareDx Inc (NASDAQ:CDNA) has a market capitalization of $905.21 Million ($905.21 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7840 globally and #4073 in its home market, demonstrating a -0.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CareDx Inc's stock price $17.60 by its total outstanding shares 51432639 (51.43 Million).
CareDx Inc Market Cap History: 2015 to 2026
CareDx Inc's market capitalization history from 2015 to 2026. Data shows growth from $329.17 Million to $905.21 Million (12.93% CAGR).
Index Memberships
CareDx Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.04% | #215 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #863 of 3165 |
Weight: CareDx Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CareDx Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CareDx Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.30x
CareDx Inc's market cap is 3.30 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
20.96x
CareDx Inc's market cap is 20.96 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $329.17 Million | $28.14 Million | -$13.71 Million | 11.70x | N/A |
| 2016 | $138.87 Million | $40.63 Million | -$39.47 Million | 3.42x | N/A |
| 2017 | $377.52 Million | $48.32 Million | -$55.47 Million | 7.81x | N/A |
| 2018 | $1.29 Billion | $76.57 Million | -$46.76 Million | 16.89x | N/A |
| 2019 | $1.11 Billion | $127.07 Million | -$21.97 Million | 8.73x | N/A |
| 2020 | $3.73 Billion | $192.19 Million | -$18.71 Million | 19.39x | N/A |
| 2021 | $2.34 Billion | $296.40 Million | -$30.66 Million | 7.89x | N/A |
| 2022 | $586.85 Million | $321.79 Million | -$76.61 Million | 1.82x | N/A |
| 2023 | $617.19 Million | $280.32 Million | -$190.28 Million | 2.20x | N/A |
| 2024 | $1.10 Billion | $333.79 Million | $52.55 Million | 3.30x | 20.96x |
Competitor Companies of CDNA by Market Capitalization
Companies near CareDx Inc in the global market cap rankings as of March 18, 2026.
Key companies related to CareDx Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
CareDx Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, CareDx Inc's market cap moved from $329.17 Million to $ 905.21 Million, with a yearly change of 12.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $905.21 Million | -6.58% |
| 2025 | $968.99 Million | -12.00% |
| 2024 | $1.10 Billion | +78.42% |
| 2023 | $617.19 Million | +5.17% |
| 2022 | $586.85 Million | -74.91% |
| 2021 | $2.34 Billion | -37.23% |
| 2020 | $3.73 Billion | +235.88% |
| 2019 | $1.11 Billion | -14.20% |
| 2018 | $1.29 Billion | +242.51% |
| 2017 | $377.52 Million | +171.85% |
| 2016 | $138.87 Million | -57.81% |
| 2015 | $329.17 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CareDx Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $905.21 Million USD |
| MoneyControl | $905.21 Million USD |
| MarketWatch | $905.21 Million USD |
| marketcap.company | $905.21 Million USD |
| Reuters | $905.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.